Literature DB >> 23608110

Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging.

Madhav Thambisetty1, Lori L Beason-Held, Yang An, Michael Kraut, Jeffrey Metter, Josephine Egan, Luigi Ferrucci, Richard O'Brien, Susan M Resnick.   

Abstract

We investigated whether individuals with impaired glucose tolerance (IGT) in midlife subsequently show regionally specific longitudinal changes in regional cerebral blood flow (rCBF) relative to those with normal glucose tolerance (NGT). Sixty-four cognitively normal participants in the neuroimaging substudy of the Baltimore Longitudinal Study of Aging underwent serial (15)O-water positron emission tomography scans (age at first scan, 69.6 ± 7.5 years) and oral glucose tolerance tests 12 years earlier (age at first oral glucose tolerance test, 57.2 ± 11.1 years). Using voxel-based analysis, we compared changes in rCBF over an 8-year period between 15 participants with IGT in midlife and 49 with NGT. Significant differences were observed in longitudinal change in rCBF between the IGT and NGT groups. The predominant pattern was greater rCBF decline in the IGT group in the frontal, parietal, and temporal cortices. Some brain regions in the frontal and temporal cortices also showed greater longitudinal increments in rCBF in the IGT group. Our findings suggest that IGT in midlife is associated with subsequent longitudinal changes in brain function during aging even in cognitively normal older individuals. Published by Elsevier Inc.

Entities:  

Keywords:  Aging; Alzheimer's; Brain function; Cerebral blood flow; Impaired glucose tolerance; Insulin resistance; PET

Mesh:

Year:  2013        PMID: 23608110      PMCID: PMC4577027          DOI: 10.1016/j.neurobiolaging.2013.03.025

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  23 in total

1.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

2.  HAMMER: hierarchical attribute matching mechanism for elastic registration.

Authors:  Dinggang Shen; Christos Davatzikos
Journal:  IEEE Trans Med Imaging       Date:  2002-11       Impact factor: 10.048

Review 3.  Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI.

Authors:  M Jueptner; C Weiller
Journal:  Neuroimage       Date:  1995-06       Impact factor: 6.556

Review 4.  Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.

Authors:  John L Petersen; Darren K McGuire
Journal:  Diab Vasc Dis Res       Date:  2005-02       Impact factor: 3.291

5.  Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.

Authors:  F de Vegt; J M Dekker; A Jager; E Hienkens; P J Kostense; C D Stehouwer; G Nijpels; L M Bouter; R J Heine
Journal:  JAMA       Date:  2001-04-25       Impact factor: 56.272

6.  The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance.

Authors:  Gian Piero Carnevale Schianca; Antonello Rossi; Pier Paolo Sainaghi; Elisabetta Maduli; Ettore Bartoli
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

Review 7.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  Glucose and insulin measurements from the oral glucose tolerance test and mortality prediction.

Authors:  E Jeffrey Metter; B Gwen Windham; Marcello Maggio; Eleanor M Simonsick; Shari M Ling; Josephine M Egan; Luigi Ferrucci
Journal:  Diabetes Care       Date:  2008-02-11       Impact factor: 19.112

10.  Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults.

Authors:  Auriel A Willette; Guofan Xu; Sterling C Johnson; Alex C Birdsill; Erin M Jonaitis; Mark A Sager; Bruce P Hermann; Asenath La Rue; Sanjay Asthana; Barbara B Bendlin
Journal:  Diabetes Care       Date:  2012-10-15       Impact factor: 19.112

View more
  20 in total

1.  Insulin resistance is associated with poorer verbal fluency performance in women.

Authors:  Laura L Ekblad; Juha O Rinne; Pauli J Puukka; Hanna K Laine; Satu E Ahtiluoto; Raimo O Sulkava; Matti H Viitanen; Antti M Jula
Journal:  Diabetologia       Date:  2015-08-15       Impact factor: 10.122

Review 2.  Type 2 diabetes and cognitive impairment: contributions from neuroimaging.

Authors:  John P Ryan; David F Fine; Caterina Rosano
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-01-05       Impact factor: 2.680

Review 3.  Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".

Authors:  Madhav Thambisetty
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-14       Impact factor: 4.249

Review 4.  Cerebrovascular complications of diabetes: focus on cognitive dysfunction.

Authors:  Trevor Hardigan; Rebecca Ward; Adviye Ergul
Journal:  Clin Sci (Lond)       Date:  2016-10-01       Impact factor: 6.124

Review 5.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

6.  Sex-specific effects of high-fat diet on cognitive impairment in a mouse model of VCID.

Authors:  Abigail E Salinero; Lisa S Robison; Olivia J Gannon; David Riccio; Febronia Mansour; Charly Abi-Ghanem; Kristen L Zuloaga
Journal:  FASEB J       Date:  2020-09-16       Impact factor: 5.191

Review 7.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

Review 8.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

9.  Blood metabolite markers of cognitive performance and brain function in aging.

Authors:  Brittany N Simpson; Min Kim; Yi-Fang Chuang; Lori Beason-Held; Melissa Kitner-Triolo; Michael Kraut; Seth T Lirette; B Gwen Windham; Michael E Griswold; Cristina Legido-Quigley; Madhav Thambisetty
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-29       Impact factor: 6.200

Review 10.  How does it STAC up? Revisiting the scaffolding theory of aging and cognition.

Authors:  Patricia A Reuter-Lorenz; Denise C Park
Journal:  Neuropsychol Rev       Date:  2014-08-21       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.